Bliss GVS Pharma Limited

NSE: BLISSGVS · Healthcare

Overview

Bliss GVS Pharma Limited Share Price & Analysis

₹467.6▼ -3.13%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹467.6
-3.13%
Open
₹—
High
₹489
Low
₹466.75
Close
₹467.6
52W High
₹553
52W Low
₹118
Volume
145K
Lot Size
1
Sector
Healthcare
Market Cap
₹5K Cr
Face Value
₹1
Mid Cap

Price Chart

Fundamentals

P/E
38.9
Sector P/E
54.4
P/B
4.14
EPS
₹10.33
ROE
11.8%
ROCE
16.9%
D/E Ratio
0.02
Div Yield
0.31%
Book Value
₹113
+

Strengths

  • ✓Efficient capital deployment (ROCE 16.9%)
  • ✓Attractively valued vs sector (P/E 38.9x vs industry 54.4x)
  • ✓Virtually debt-free

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

BLISSGVS · as of Mar 2026

Promoters35.29%▲0.19
FII13.18%▼0.33
DII6.55%
Public44.98%▲0.14
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters34.97%34.97%34.90%34.82%35.10%35.29%
FII15.35%14.74%13.24%12.13%13.51%13.18%
DII6.60%6.59%6.58%6.56%6.55%6.55%
Public43.08%43.71%45.27%46.49%44.84%44.98%

Corporate Events

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

Dividend11 May 2026

Interim Dividend - Re 0.50 Per Share

Dividend17 Feb 2026

Annual General Meeting/Dividend - Rs 0.50 Per Share

Dividend23 Jul 2025

Annual General Meeting/Dividend - Rs 0.50 Per Share

Dividend17 Jul 2024

Annual General Meeting/Dividend - Re 0.50 Per Share

Dividend11 Jul 2023

Latest News

All news →

Bliss GVS Pharma hits 52-week high on WHO approval and strong earnings

*Bliss GVS Pharma hits 52-week high on WHO approval and strong earnings* — Shares of Bliss GVS Pharma surged to a 52-week high of **₹447** following WHO's approval of its manufacturing facility. The stock rallied on the back of strong quarterly earnings and positive sentiment from a recent acquisition. Investors are optimistic about expanded global market access and future revenue growth. 📊 *STOCKS:* BLISSGVS | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Pharma

India Infoline3 Jun
High Impact

Bliss GVS Pharma shares unaffected; updates KMP contact details

*Bliss GVS Pharma updates contact details of Key Management Personnel for reporting material events.* This is a routine compliance disclosure with no immediate financial impact. **No trading-sensitive information** or strategic changes disclosed. Investors advised to monitor for future announcements. 📊 *STOCKS:* BGL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #KMP

NSE Filing15 Jul
Low Impact

Bliss GVS Pharma announces 41st AGM via newspaper notice

*Bliss GVS Pharma announces 41st AGM via newspaper publication.* The date, time, and agenda of the meeting will be disclosed as per regulatory norms. Shareholders are advised to watch for further announcements. Dividend details, if any, will be revealed during the meet. 📊 *STOCKS:* BLISSGVS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

NSE Filing19 Jun
Low Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹218 Cr
▼10.7%
₹244 Cr
▲17.9%
₹207 Cr
▲4.5%
₹198 Cr
▼5.7%
₹210 Cr
▼3.7%
₹218 Cr
▲18.5%
₹184 Cr
▼7.1%
₹198 Cr
Op. Profit
₹35 Cr
▼18.6%
₹43 Cr
▲4.9%
₹41 Cr
▲95.2%
₹21 Cr
▼30.0%
₹30 Cr
▼26.8%
₹41 Cr
▲20.6%
₹34 Cr
▲21.4%
₹28 Cr
OPM
16.0%
▼11.1%
18.0%
▼10.0%
20.0%
▲81.8%
11.0%
▼21.4%
14.0%
▼26.3%
19.0%
▲0.0%
19.0%
▲35.7%
14.0%
Net Profit
₹25 Cr
▼13.8%
₹29 Cr
▼34.1%
₹44 Cr
▲158.8%
₹17 Cr
▼34.6%
₹26 Cr
▲0.0%
₹26 Cr
▲18.2%
₹22 Cr
▲540.0%
₹-5 Cr
EPS (₹)
2.2
▼14.7%
2.58
▼36.8%
4.08
▲177.6%
1.47
▼35.0%
2.26
▼2.2%
2.31
▲17.3%
1.97
▲326.4%
-0.87

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹927 Cr
▲14.4%
₹810 Cr
▲5.2%
₹770 Cr
▲2.4%
₹752 Cr
▲0.7%
₹747 Cr
▲29.5%
₹577 Cr
▼16.3%
₹689 Cr
▼23.4%
₹899 Cr
▲10.3%
₹815 Cr
▲2.1%
₹798 Cr
Expenses
₹763 Cr
▲11.7%
₹683 Cr
▲10.2%
₹620 Cr
▼2.2%
₹634 Cr
▲0.8%
₹629 Cr
▲33.5%
₹471 Cr
▼16.8%
₹566 Cr
▼23.4%
₹739 Cr
▲19.6%
₹618 Cr
▲3.7%
₹596 Cr
Op. Profit
₹164 Cr
▲29.1%
₹127 Cr
▼15.9%
₹151 Cr
▲29.1%
₹117 Cr
▼0.8%
₹118 Cr
▲10.3%
₹107 Cr
▼13.0%
₹123 Cr
▼23.1%
₹160 Cr
▼18.8%
₹197 Cr
▼3.0%
₹203 Cr
OPM
18.0%
▲12.5%
16.0%
▼20.0%
20.0%
▲25.0%
16.0%
▲0.0%
16.0%
▼11.1%
18.0%
▲0.0%
18.0%
▲0.0%
18.0%
▼25.0%
24.0%
▼4.0%
25.0%
Other Income
₹71 Cr
▲97.2%
₹36 Cr
₹0 Cr
▼100.0%
₹18 Cr
▲142.9%
₹-42 Cr
▼310.0%
₹20 Cr
▼23.1%
₹26 Cr
▼25.7%
₹35 Cr
▲537.5%
₹-8 Cr
▼166.7%
₹12 Cr
Interest
₹12 Cr
▲50.0%
₹8 Cr
▲14.3%
₹7 Cr
▼30.0%
₹10 Cr
▲100.0%
₹5 Cr
▼16.7%
₹6 Cr
▼25.0%
₹8 Cr
▲100.0%
₹4 Cr
▼82.6%
₹23 Cr
▲15.0%
₹20 Cr
Depreciation
₹33 Cr
▲13.8%
₹29 Cr
▲11.5%
₹26 Cr
▲36.8%
₹19 Cr
▲11.8%
₹17 Cr
▲0.0%
₹17 Cr
▲30.8%
₹13 Cr
▲44.4%
₹9 Cr
▼57.1%
₹21 Cr
▲5.0%
₹20 Cr
PBT
₹190 Cr
▲50.8%
₹126 Cr
▲7.7%
₹117 Cr
▲10.4%
₹106 Cr
▲96.3%
₹54 Cr
▼48.1%
₹104 Cr
▼19.4%
₹129 Cr
▼29.1%
₹182 Cr
▲25.5%
₹145 Cr
▼17.1%
₹175 Cr
Tax %
29.0%
▲3.6%
28.0%
▼6.7%
30.0%
▲7.1%
28.0%
▼50.9%
57.0%
▲96.6%
29.0%
▲11.5%
26.0%
▼13.3%
30.0%
▼23.1%
39.0%
▲8.3%
36.0%
Net Profit
₹135 Cr
▲50.0%
₹90 Cr
▲9.8%
₹82 Cr
▲6.5%
₹77 Cr
▲234.8%
₹23 Cr
▼68.9%
₹74 Cr
▼22.1%
₹95 Cr
▼25.2%
₹127 Cr
▲42.7%
₹89 Cr
▼21.2%
₹113 Cr
EPS (₹)
12.21
▲52.6%
8
▲11.0%
7.21
▲6.0%
6.8
▲369.0%
1.45
▼78.2%
6.64
▼29.6%
9.43
▼21.4%
11.99
▲110.4%
5.7
▼28.3%
7.95
Div Payout
8.0%
▲33.3%
6.0%
▼14.3%
7.0%
▲0.0%
7.0%
▼79.4%
34.0%
▲325.0%
8.0%
▲60.0%
5.0%
▼37.5%
8.0%
▼55.6%
18.0%
▲125.0%
8.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹11 Cr
▲0.0%
₹11 Cr
▲10.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
Reserves
₹1.1K Cr
▲7.9%
₹1.0K Cr
▲8.7%
₹957 Cr
▲9.6%
₹873 Cr
▲8.0%
₹808 Cr
▲1.3%
₹798 Cr
▲10.1%
₹725 Cr
▲14.0%
₹636 Cr
▲20.9%
₹526 Cr
▲10.5%
₹476 Cr
Borrowings
₹52 Cr
▼40.9%
₹88 Cr
▼12.0%
₹100 Cr
▼2.0%
₹102 Cr
▼6.4%
₹109 Cr
▼10.7%
₹122 Cr
▼3.2%
₹126 Cr
▲23.5%
₹102 Cr
▼13.6%
₹118 Cr
▼47.6%
₹225 Cr
Other Liabilities
₹215 Cr
▲32.7%
₹162 Cr
▲11.7%
₹145 Cr
▼15.2%
₹171 Cr
▼5.5%
₹181 Cr
▲23.1%
₹147 Cr
▼12.5%
₹168 Cr
▲7.0%
₹157 Cr
▼23.8%
₹206 Cr
▼33.8%
₹311 Cr
Total Liabilities
₹1.4K Cr
▲7.6%
₹1.3K Cr
▲7.3%
₹1.2K Cr
▲4.8%
₹1.2K Cr
▲4.3%
₹1.1K Cr
▲3.0%
₹1.1K Cr
▲4.6%
₹1.0K Cr
▲13.8%
₹905 Cr
▲5.2%
₹860 Cr
▼15.9%
₹1.0K Cr
Assets
Fixed Assets
₹392 Cr
▼3.4%
₹406 Cr
▲9.7%
₹370 Cr
▼2.4%
₹379 Cr
▲34.9%
₹281 Cr
▲20.1%
₹234 Cr
▼3.3%
₹242 Cr
▲65.8%
₹146 Cr
▲2.1%
₹143 Cr
▼53.1%
₹305 Cr
CWIP
₹39 Cr
▲85.7%
₹21 Cr
▲162.5%
₹8 Cr
▲166.7%
₹3 Cr
▼86.4%
₹22 Cr
▲1000.0%
₹2 Cr
₹0 Cr
▼100.0%
₹47 Cr
₹0 Cr
▼100.0%
₹4 Cr
Investments
₹10 Cr
▲150.0%
₹4 Cr
▲0.0%
₹4 Cr
▼50.0%
₹8 Cr
▲300.0%
₹2 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
Other Assets
₹959 Cr
▲10.2%
₹870 Cr
▲4.8%
₹830 Cr
▲8.1%
₹768 Cr
▼4.4%
₹803 Cr
▼4.4%
₹840 Cr
▲6.6%
₹788 Cr
▲10.7%
₹712 Cr
▼0.7%
₹717 Cr
▲0.4%
₹714 Cr
Total Assets
₹1.4K Cr
▲7.6%
₹1.3K Cr
▲7.3%
₹1.2K Cr
▲4.8%
₹1.2K Cr
▲4.3%
₹1.1K Cr
▲3.0%
₹1.1K Cr
▲4.6%
₹1.0K Cr
▲13.8%
₹905 Cr
▲5.2%
₹860 Cr
▼15.9%
₹1.0K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹106 Cr
▲2.9%
₹103 Cr
▲202.9%
₹34 Cr
▼74.8%
₹135 Cr
▲110.9%
₹64 Cr
▲36.2%
₹47 Cr
▲17.5%
₹40 Cr
▲122.2%
₹18 Cr
▼93.8%
₹289 Cr
▲155.8%
₹113 Cr
Investing CF
₹-75 Cr
▲9.6%
₹-83 Cr
▼1283.3%
₹-6 Cr
▲94.2%
₹-103 Cr
▼128.9%
₹-45 Cr
▼12.5%
₹-40 Cr
▲49.4%
₹-79 Cr
▼264.6%
₹48 Cr
▲119.3%
₹-249 Cr
▼398.0%
₹-50 Cr
Financing CF
₹-30 Cr
▼42.9%
₹-21 Cr
▲16.0%
₹-25 Cr
▼4.2%
₹-24 Cr
▼14.3%
₹-21 Cr
▼250.0%
₹-6 Cr
▼135.3%
₹17 Cr
▲122.4%
₹-76 Cr
▼660.0%
₹-10 Cr
▲75.0%
₹-40 Cr
Net Cash Flow
₹0 Cr
▲100.0%
₹-1 Cr
▼133.3%
₹3 Cr
▼66.7%
₹9 Cr
▲550.0%
₹-2 Cr
₹0 Cr
▲100.0%
₹-22 Cr
▼120.0%
₹-10 Cr
▼133.3%
₹30 Cr
▲30.4%
₹23 Cr
Free Cash Flow
₹33 Cr
▼56.0%
₹75 Cr
▲227.1%
₹-59 Cr
▼193.7%
₹63 Cr
▲14.5%
₹55 Cr
▲558.3%
₹-12 Cr
▼700.0%
₹2 Cr
▲128.6%
₹-7 Cr
▼103.8%
₹186 Cr
▲84.2%
₹101 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
198d
▲3.1%
192d
▲2.7%
187d
▼2.6%
192d
▼34.5%
293d
▲1.0%
290d
▲55.1%
187d
▲39.6%
134d
▲15.5%
116d
▼42.3%
201d
Inventory Days
111d
▼1.8%
113d
▲20.2%
94d
▼19.0%
116d
▲5.5%
110d
▲71.9%
64d
▲39.1%
46d
▼16.4%
55d
▲10.0%
50d
▼9.1%
55d
Days Payable
63d
▲8.6%
58d
▼26.6%
79d
▼8.1%
86d
▲4.9%
82d
▲9.3%
75d
▲59.6%
47d
▼14.5%
55d
▼45.0%
100d
▼34.6%
153d
Cash Conv. Cycle
246d
▼0.4%
247d
▲22.3%
202d
▼8.6%
221d
▼31.2%
321d
▲15.1%
279d
▲50.0%
186d
▲38.8%
134d
▲100.0%
67d
▼34.3%
102d
Working Capital Days
199d
▼3.9%
207d
▲7.8%
192d
▲7.3%
179d
▼32.2%
264d
▲13.8%
232d
▲50.6%
154d
▲14.1%
135d
▲1450.0%
-10d
▼111.9%
84d
ROCE
12.0%
▼14.3%
14.0%
▲16.7%
12.0%
▼14.3%
14.0%
▲16.7%
12.0%
▼33.3%
18.0%
▼30.8%
26.0%
▼3.7%
27.0%
▼6.9%
29.0%
▼6.5%
31.0%

Source: Screener.in · Lower days = better efficiency

About Bliss GVS Pharma Limited

Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Bliss GVS Pharma Limited share price today?▾
Bliss GVS Pharma Limited (BLISSGVS) is currently trading at ₹467.6 on NSE, down 3.13% as of the last market session. Prices update daily after market close on MarketNetra.
Is Bliss GVS Pharma Limited available in F&O (Futures & Options)?▾
Yes, Bliss GVS Pharma Limited (BLISSGVS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Bliss GVS Pharma Limited 52-week high and low?▾
Bliss GVS Pharma Limited's 52-week high is ₹553 and the 52-week low is ₹118. The current price of ₹467.6 is 15.4% below the 52W high.
What is Bliss GVS Pharma Limited P/E ratio?▾
Bliss GVS Pharma Limited's current P/E ratio is 38.9. This indicates the market is paying ₹38.9 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Bliss GVS Pharma Limited options?▾
Bliss GVS Pharma Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BLISSGVS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.